Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2018, Article ID 5349837, 7 pages
https://doi.org/10.1155/2018/5349837
Research Article

A Granulocyte-Specific Protein S100A12 as a Potential Prognostic Factor Affecting Aggressiveness of Therapy in Patients with Juvenile Idiopathic Arthritis

Department of Pediatric Cardiology and Rheumatology, Medical University of Lodz, Sporna 36/50, 91-738 Lodz, Poland

Correspondence should be addressed to Elzbieta Smolewska; lp.pw@aksweloms.e

Received 26 June 2018; Revised 16 September 2018; Accepted 25 September 2018; Published 22 October 2018

Guest Editor: Yi Zhao

Copyright © 2018 Krzysztof Orczyk and Elzbieta Smolewska. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Opoka-Winiarska, Z. Żuber, and E. Smolewska, “Diagnostyka i leczenie młodzieńczego idiopatycznego zapalenia stawów–praktyczne wskazówki dla pediatry,” Pediatria po Dyplomie, vol. 21, no. 3, pp. 6–18, 2017. View at Google Scholar
  2. R. E. Petty, T. R. Southwood, P. Manners et al., “International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001,” The Journal of Rheumatology, vol. 31, no. 2, pp. 390–392, 2004. View at Google Scholar
  3. L. Aoust, L. Rossi-Semerano, I. Koné-Paut, and P. Dusser, “Time to diagnosis in juvenile idiopathic arthritis: a French perspective,” Orphanet Journal of Rare Diseases, vol. 12, no. 1, p. 43, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Guzman, A. Henrey, T. Loughin et al., “Predicting which children with juvenile idiopathic arthritis will have a severe disease course: results from the ReACCh-Out cohort,” The Journal of Rheumatology, vol. 44, no. 2, pp. 230–240, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Consolaro, N. Ruperto, A. Bazso et al., “Development and validation of a composite disease activity score for juvenile idiopathic arthritis,” Arthritis and Rheumatism, vol. 61, no. 5, pp. 658–666, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Bazso, A. Consolaro, N. Ruperto et al., “Development and testing of reduced joint counts in juvenile idiopathic arthritis,” The Journal of Rheumatology, vol. 36, no. 1, pp. 183–190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Ravelli, A. Consolaro, G. Horneff et al., “Treating juvenile idiopathic arthritis to target: recommendations of an international task force,” Annals of the Rheumatic Diseases, vol. 77, no. 6, pp. 819–828, 2018. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Hinze, F. Gohar, and D. Foell, “Management of juvenile idiopathic arthritis: hitting the target,” Nature Reviews Rheumatology, vol. 11, no. 5, pp. 290–300, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. C. A. Wallace, E. H. Giannini, S. J. Spalding et al., “Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis,” Arthritis and Rheumatism, vol. 64, no. 6, pp. 2012–2021, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Š. Blazina, G. Markelj, M. Z. Avramovič, N. Toplak, and T. Avčin, “Management of juvenile idiopathic arthritis: a clinical guide,” Paediatric Drugs, vol. 18, no. 6, pp. 397–412, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Ravelli, S. Davì, G. Bracciolini et al., “Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial,” Lancet, vol. 389, no. 10072, pp. 909–916, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wang, F. Pei, X. Wang, Z. Sun, C. Hu, and H. Dou, “Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody for juvenile idiopathic arthritis,” Journal of Immunology Research, vol. 2015, Article ID 915276, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Gohar, C. Kessel, M. Lavric, D. Holzinger, and D. Foell, “Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?” Arthritis Research & Therapy, vol. 18, no. 1, p. 163, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Vogl, C. Pröpper, M. Hartmann et al., “S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14,” The Journal of Biological Chemistry, vol. 274, no. 36, pp. 25291–25296, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Hofmann, S. Drury, C. Fu et al., “RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides,” Cell, vol. 97, no. 7, pp. 889–901, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Hofmann, S. Drury, B. I. Hudson et al., “RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response,” Genes and Immunity, vol. 3, no. 3, pp. 123–135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Rouleau, K. Vandal, C. Ryckman et al., “The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis,” Clinical Immunology, vol. 107, no. 1, pp. 46–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Foell, D. Kane, B. Bresnihan et al., “Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis,” Rheumatology, vol. 42, no. 11, pp. 1383–1389, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Foell, T. Kucharzik, M. Kraft et al., “Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease,” Gut, vol. 52, no. 6, pp. 847–853, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Foell, F. Ichida, T. Vogl et al., “S100A12 (EN-RAGE) in monitoring Kawasaki disease,” Lancet, vol. 361, no. 9365, pp. 1270–1272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Foell, H. Wittkowski, I. Hammerschmidt et al., “Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations,” Arthritis and Rheumatism, vol. 50, no. 4, pp. 1286–1295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Yamasaki, S. Takei, H. Imanaka et al., “Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factor,” Modern Rheumatology, vol. 26, no. 4, pp. 551–556, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Gerss, J. Roth, D. Holzinger et al., “Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study,” Annals of the Rheumatic Diseases, vol. 71, no. 12, pp. 1991–1997, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Gohar, J. Anink, H. Moncrieffe et al., “S100A12 is associated with response to therapy in juvenile idiopathic arthritis,” The Journal of Rheumatology, vol. 45, no. 4, pp. 547–554, 2018. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Consolaro, G. Bracciolini, N. Ruperto et al., “Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score,” Arthritis and Rheumatism, vol. 64, no. 7, pp. 2366–2374, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Consolaro, N. Ruperto, G. Bracciolini et al., “Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score,” Annals of the Rheumatic Diseases, vol. 73, no. 7, pp. 1380–1383, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Bojko, “Measurement of blood calprotectin (MRP-8/MRP-14) levels in patients with juvenile idiopathic arthritis,” Reumatologia, vol. 1, pp. 18–22, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Giancane, A. Alongi, S. Rosina, S. Calandra, A. Consolaro, and A. Ravelli, “Open issues in the assessment and management of pain in juvenile idiopathic arthritis,” Clinical and Experimental Rheumatology, vol. 35, Supplement 107, pp. S123–S126, 2017. View at Google Scholar
  29. A. Rashid, L. Cordingley, R. Carrasco et al., “Patterns of pain over time among children with juvenile idiopathic arthritis,” Archives of Disease in Childhood, vol. 103, no. 5, pp. 437–443, 2018. View at Publisher · View at Google Scholar
  30. R. A. Cai, D. Beste, H. Chaplin et al., “Developing and evaluating JIApp: acceptability and usability of a smartphone app system to improve self-management in young people with juvenile idiopathic arthritis,” JMIR mHealth and uHealth, vol. 5, no. 8, article e121, 2017. View at Publisher · View at Google Scholar